News – Page 1114 – Endpoints News

Editas loses its lead in the biotech race to launch the first CRISPR/Cas9 human study

8 years ago

FDA commissioner Scott Gottlieb sets some goals: Find ways to lower drug prices, use new tech to speed development

8 years ago

Akebia adds $50M deal with Vifor for exclusive US distribution deal for vadadustat

8 years ago

With major backing from New York and China, Athenex sets sights on a $100M cancer drug IPO

8 years ago

Biogen CSO Artavanis-Tsakonas heads back to Harvard, lab funding in hand

8 years ago

Ignyta jumps on an FDA ‘breakthrough’ nod for entrectinib; Thermo Fisher buying Patheon in $7.2B deal

8 years ago

Can Dendreon’s new Provenge data help ignite a turnaround for the faded cancer star?

8 years ago

Genoa Pharma grabs a $62M A round to back its oral IPF drug Aerodone

8 years ago

Focused on new deals, Biogen bags a PhIII drug for ischemic stroke with $120M upfront

8 years ago

Ionis says it gathered promising PhIII data for a top rare disease drug, but serious safety questions remain

8 years ago

Genzyme founder, biotech entrepreneur and industry legend Henri Termeer dies

8 years ago

Alnylam adds a slate of new executives; Thomas Insel is leaving Verily; Akari CEO Gur Roshwalb placed on leave

8 years ago

Capricor shares blasted as PhII heart study fails; Sanofi to destroy unused facility in France

8 years ago

Biogen shutters a biotech shop in the UK as it continues to prune R&D

8 years ago

Glaxit: Flagging a looming threat from Gilead and a weak pipeline, Neil Woodford is giving up on GSK and pulling out

8 years ago

Playing catch-up, Eli Lilly is hustling positive PhIII CGRP migraine data to the FDA as late-stage rivalry heats up

8 years ago

Ardelyx rolls out positive PhIII IBS-C data on tenapanor as rivals prep for a showdown, but shares crater

8 years ago

AstraZeneca’s shares spike on a surprise coup in PhIII lung cancer data

8 years ago

Scott Gottlieb is sworn in as FDA commissioner

8 years ago

Regulators order AB Science to halt trial work on PhIII ALS drug, demanding proof it's cleaned up

8 years ago

Astellas dumps a PhIII lung cancer drug; GSK gets one success, one failure in a pair of pivotal Crohn’s trials

9 years ago

Shares soar as ‘breakthrough’ news in biotech continues to run hot this week

9 years ago

It’s all quite satisfactory, merci: Sanofi chairman Serge Weinberg shrugs off growing calls for an M&A deal

9 years ago

Daiichi Sankyo sweeps out Pieris drug, 5 others in a Q1 pipeline cleanup

9 years ago

First page Previous page 1111 1112 111311141115 1116 1117 Next page Last page